Chinese Journal of Tissue Engineering Research ›› 2014, Vol. 18 ›› Issue (32): 5091-5096.doi: 10.3969/j.issn.2095-4344.2014.32.002

Previous Articles     Next Articles

Mangiferin protects bone marrow mesenchymal stem cells against hypoxia

Cheng Jian-wen, Zhao Jin-min, Li Xiao-feng, Tan Zhen   

  1. Department of Traumatic Orthopaedics and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Received:2014-07-08 Online:2014-08-06 Published:2014-09-18
  • Contact: Zhao Jin-min, M.D., Professor, Department of Traumatic Orthopaedics and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • About author:Cheng Jian-wen, Studying for doctorate, Attending physician, Department of Traumatic Orthopaedics and Hand Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Supported by:

    the Special Scientific Fund for Traditional Chinese Medicine in Guangxi Health Bureau, No. GZKZ 10-011, GZKZ-Z1104; the Research Fund for the Doctoral Program of Higher Education, No. 20104503110002; Key Technology Research and Development Projects of Population Health and Food Safety of Guangxi Science and Technology Bureau, No. guikegong 1140003A-31; Self-Funded Research Projects of Guangxi Health Bureau, No. guiweiZ2012058, guiweiZ2012061; Projects of Guangxi Education Bureau, No. guijiao201010LX050

Abstract:

BACKGROUND: Bone marrow mesenchymal stem cells have particularly applied prospects in tissue engineering. However, the death of transplanted cells limits the tissue regeneration. To search a new drug of anti-free radicals and protecting bone marrow mesenchymal stem cells is of great significance.
OBJECTIVE: To investigate the protective effects of mangiferin on bone marrow mesenchymal stem cells against hypoxia.
METHODS: Rat bone marrow mesenchymal stem cells were cultured in vitro and hypoxia cell model was established by cobalt chloride. Cells were divided into normal control group, hypoxia group (treated with cobalt chloride), and mangiferin groups (cobalt chloride+20, 40, 80, 160 µmol/L mangiferin). After 12 and 24 hours of hypoxia, superoxide dismutase, malondialdehyde, and catalase levels in the cell supernatant were determined. After 3, 6, 12, 24 hours of hypoxia, reactive oxygen species change was detected in each group.
RESULTS AND CONCLUSION: Mangiferin significantly improved the survival rate of bone marrow mesenchymal stem cells exposed to hypoxia, increased the intracellular superoxide dismutase and catalase activities, decreased intracellular malondialdehyde and reactive oxygen species levels, thereby effectively protecting bone marrow mesenchymal stem cells against hypoxia. These findings indicate that mangiferin has effective protection against hypoxia and strong antioxidant ability, and can significantly reduce oxidative damage.


中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程


全文链接:

Key words: bone marrow, mesenchymal stem cells, anoxia, mangifera

CLC Number: